Mechanism underlying endothelium-dependent relaxation by 2-methylthio-ADP in monkey cerebral artery

Journal of Pharmacological Sciences

Volumn 114, Issue 2, 2010, Pages 180-188

  Geddawy, Ayman ^a,b   Shimosato, Takashi ^a   Tawa, Masashi ^a   Imamura, Takeshi ^a   Okamura, Tomio ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Minia University   (Egypt)

Author keywords

Endothelium dependent relaxation; Epoxyeicosatrienoic acid; Monkey cerebral artery

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; 2 METHYLTHIO ADENOSINE DIPHOSPHATE; 2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; APAMIN; ARACHIDONYL TRIFLUOROMETHYL KETONE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHARYBDOTOXIN; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; FORSKOLIN; GLIBENCLAMIDE; IBERIOTOXIN; INDOMETACIN; KETOCONAZOLE; N(G) NITROARGININE; NITROPRUSSIDE SODIUM; PHOSPHOLIPASE A2; PROSTAGLANDIN F2 ALPHA; PURINERGIC P2Y RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; BRAIN ARTERY; BRAIN BLOOD FLOW; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; MALE; MONKEY; NONHUMAN; VASODILATATION;

EID: 78349286719     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10144FP     Document Type: Article

References (36)

1. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev. 2006;58:58-86.
2. Erlinge D, Burnstock G. P2 receptors in cardiovascular regulation and disease. Purinergic Signal. 2008;4:1-20.
3. Potter P, White TD. Release of adenosine 5-triphosphate from synaptosomes from different regions of rat brain. Neuroscience. 1980;5:1351-1356.
4. Hardebo JE, Kahrstrom J, Owman C. P1 and P2 purine receptors in brain circulation. Eur J Pharmacol. 1987;144:343-352.
5. Burnstock G. Purinergic signaling. Br J Pharmacol. 2006;147: S172-S181.
6. Olivecrona GK, Gotberg M, Harnek J, Wang L, Jacobson KA, Erlinge D. Coronary artery reperfusion: the ADP receptor P2Y1 mediates early reactive hyperemia in vivo in pigs. Purinergic Signalling. 2006;1:59-64.
7. Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev. 2009;61: 62-97.
8. Toda N, Okamura T. Cerebral vasodilators. Jpn J Pharmacol. 1998;76:349-367.
9. Bellien J, Thuillez C, Joannides R. Contribution of endotheliumderived hyperpolarizing factors to the regulation of vascular tone in humans. Fundam Clin Pharmacol. 2008;22:363-377.
10. Toda N, Kawakami M, Yamazaki M, Okamura T. Comparison of endothelium-dependent responses of monkey cerebral and temporal arteries. Br J Pharmacol. 1991;102:805-810.
11. Ayajiki K, Fujioka H, Torii R, Toda N, Okamura T. Endothelial and neuronal functions in cerebral and temporal arteries from monkeys fed a high-cholesterol diet. J Cardiovasc Pharmacol. 2002;40:456-466.
12. Geddawy A, Shimosato T, Tawa M, Imamura T, Okamura T. Comparison of endothelium-related responses to nucleotides of dog and monkey cerebral arteries. J Pharmacol Sci. 2010;112: 378-381.
13. Toda N, Hatano Y, Hayashi S. Modifications by stretches of the mechanical response of isolated cerebral and extracerebral arteries to vasoactive agents. Pflugers Arch. 1978;374:73-77.
14. Rodríguez-Rodríguez R, Yarova P, Winter P, Dora KA. Desensitization of endothelial P2Y1 receptors by PKC-dependent mechanisms in pressurized rat small mesenteric arteries. Br J Pharmacol. 2009;158:1609-1620.
15. Fujioka H, Ayajiki K, Shinozaki K, Toda N, Okamura T. Mechanisms underlying endothelium-dependent, nitric oxide- and prostanoid-independent relaxation in monkey and dog coronary arteries. Naunyn Schmiedebergs Arch Pharmacol. 2002;366: 488-495.
16. Sandow SL, Tare M, Coleman HA, Hill CE, Parkington HC. Involvement of myoendothelial gap junctions in the action of endothelium-derived hyperpolarizing factor. Circ Res. 2002;90: 1108-1113.
17. Ayajiki K, Okamura T, Fujioka H, Imaoka S, Funae Y, Toda N. Involvement of CYP3A-derived arachidonic acid metabolite(s) in responses to endothelium-derived K+ channel opening substance in monkey lingual artery. Br J Pharmacol. 1999;128: 802-808.
18. Toda N, Ayajiki K, Okamura T. Cerebroarterial relaxations mediated by nitric oxide derived from endothelium and vasodilator nerve. J Vasc Res. 1993;30:61-67.
19. You J, Johnson TD, Childres WF, Bryan RM Jr. Endothelialmediated dilations of rat middle cerebral arteries by ATP and ADP. Am J Physiol. 1997;273:H1472-H1477.
20. Faraci FM, Lynch C, Lamping KG. Responses of cerebral arterioles to ADP: eNOS-dependent and eNOS-independent mechanisms. Am J Physiol Heart Circ Physiol. 2004;287:H2871- H2876.
21. Wang L, Karlsson L, Moses S, Hultgårdh-Nilsson A, Andersson M, Borna C, et al. P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol. 2002;40:841-853.
22. You J, Johnson TD, Marelli SP, Mombouli JV, Bryan RM Jr. P2u receptor mediated release of endothelium-derived relaxing factor/ nitric oxide and endothelium-derived hyperpolarizing factor from cerebrovascular endothelium in rats. Stroke. 1999;30: 1125-1133.
23. Mistry H, Gitlin JM, Mitchell JA, Hiley CR. Endotheliumdependent relaxation and endothelial hyperpolarization by P2Y receptor agonists in rat-isolated mesenteric artery. Br J Pharmacol. 2003;139:661-671.
24. Malmsjø M, Chu ZM, Croft K, Erlinge D, Edvinsson L, Beilin LJ. P2Y receptor-induced EDHF vasodilatation is of primary importance for the regulation of perfusion pressure in the peripheral circulation of the rat. Acta Physiol Scand. 2002;174: 301-309.
25. Wihlborg AK, Malmsjö M, Eyjolfsson A, Gustafsson R, Jacobson K, Erlinge D. Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endotheliumderived hyperpolarising factor. Br J Pharmacol. 2003;138:1451-1458.
26. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999;401:493-497.
27. + channels. Circ Res. 1998;83:501-507.
28. 2 in endothelium-derived hyperpolarizing factor dilations of rat middle cerebral arteries. J Cereb Blood Flow Metab. 2002;10:1239-1247.
29. Dong H, Jiang Y, Cole WC, Triggle CR. Comparison of the pharmacological properties of EDHF-mediated vasorelaxation in guinea-pig cerebral and mesenteric resistance vessels. Br J Pharmacol. 2000;130:1983-1991.
30. Ayajiki K, Fujioka H, Toda N, Okada S, Minamiyama Y, Imaoka S, et al. Mediation of arachidonic acid metabolite(s) produced by endothelial cytochrome P-450 3A4 in monkey arterial relaxation. Hypertens Res. 2003;26:237-243.
31. Iliff JJ, Jia J, Nelson J, Goyagi T, Klaus J, Alkayed NJ. Epoxyeicosanoid signaling in CNS function and disease. Prostaglandins Other Lipid Mediat. 2010;91:68-84.
32. Gebremedhin D, Ma YH, Falck JR, Roman RJ, Van Rollins M, Harder DR. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol Heart Circ Physiol. 1992;263:H519-H525.
33. Ellis EF, Police RJ, Yancey L, McKinney JS, Amruthesh SC. Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol Heart Circ Physiol. 1990; 259:H1171-H1177.
34. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium derived hyperpolarizing factors. Circ Res. 1996;78:415-423.
35. Gauthier KM, Edwards EM, Falck JR, Reddy DS, Campbell WB. 14, 15-Epoxyeicosatrienoic acid represents a transferable endothelium-dependent relaxing factor in bovine coronary arteries. Hypertension. 2005;45:666-671.
36. Archer SL, Gragasin FS, Wu X, Wang S, McMurtry S, Kim DH, et al. Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BKca channels. Circulation. 2003;107:769-776.